Moreover, the P2Y—like G protein-coupled receptor 17 (GPR17), which has been previously characterized as a good pharmacological target to implement repair and remyelination under several neurodegenerative conditions including multiple sclerosis, was reported to be expressed at a much higher level in the spinal cord from SOD1G93A mice compared to healthy animals. The gene discussed is GPR17; the disease is multiple sclerosis.